Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies
Open accessThe DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index, and 1 are not checked yet; none of the 9 sources its claims cite is checked for support yet.
Abstract
BACKGROUND: Positive association between obesity and survival after breast cancer was demonstrated in previous meta-analyses of published data, but only the results for the comparison of obese versus non-obese was summarised. METHODS: We systematically searched in MEDLINE and EMBASE for follow-up studies of breast cancer survivors with body mass index (BMI) before and after diagnosis, and total and cause-specific mortality until June 2013, as part of the World Cancer Research Fund Continuous Update Project. Random-effects meta-analyses were conducted to explore the magnitude and the shape of the associations. RESULTS: Eighty-two studies, including 213 075 breast cancer survivors with 41 477 deaths (23 182 from breast cancer) were identified. For BMI before diagnosis, compared with normal weight women, the summary relative risks (RRs) of total mortality were 1.41 [95% confidence interval (CI) 1.29-1.53] for obese (BMI >30.0), 1.07 (95 CI 1.02-1.12) for overweight (BMI 25.0-<30.0) and 1.10 (95% CI 0.92-1.31) for underweight (BMI <18.5) women. For obese women, the summary RRs were 1.75 (95% CI 1.26-2.41) for pre-menopausal and 1.34 (95% CI 1.18-1.53) for post-menopausal breast cancer. For each 5 kg/m(2) increment of BMI before, <12 months after, and ≥12 months after diagnosis, increased risks of 17%, 11%, and 8% for total mortality, and 18%, 14%, and 29% for breast cancer mortality were observed, respectively. CONCLUSIONS: Obesity is associated with poorer overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained. Being overweight is also related to a higher risk of mortality. Randomised clinical trials are needed to test interventions for weight loss and maintenance on survival in women with breast cancer.
Checked 2026-10-11 · 1 reference not checked yet
Overview
CoChat Summary
## TL;DR
This systematic review and meta-analysis of 82 follow-up studies found that higher BMI was associated with worse overall and breast cancer survival in women with breast cancer, whether BMI was measured before diagnosis, <12 months after, or ≥12 months after diagnosis. It also found some increased mortality risk in overweight and underweight women and evidence of a J-shaped BMI–total mortality relationship.
## Key findings
- Across 79 publications from 82 follow-up studies, the meta-analyses included 41,477 deaths (23,182 from breast cancer) among 213,075 breast cancer survivors.
- For total mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
- before diagnosis: RR 1.41 (95% CI 1.29–1.53; 21 studies)
- <12 months after diagnosis: RR 1.23 (95% CI 1.12–1.33; 24 studies)
- ≥12 months after diagnosis: RR 1.21 (95% CI 1.06–1.38; 5 studies)
- For breast cancer mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
- before diagnosis: RR 1.35 (95% CI 1.24–1.47; 22 studies)
- <12 months after diagnosis: RR 1.25 (95% CI 1.10–1.42; 12 studies)
- ≥12 months after diagnosis: RR 1.68 (95% CI 0.90–3.15; 2 studies; not statistically significant)
- Linear dose–response analyses showed increased risk per 5 kg/m² higher BMI:
- Total mortality: RR 1.17 before diagnosis, 1.11 <12 months after, 1.08 ≥12 months after
- Breast cancer mortality: RR 1.18 before diagnosis, 1.14 <12 months after
- The paper reports a J-shaped association for total mortality and notes that risks were also elevated in overweight and, in some analyses, underweight women.
## Methods
- Design: Systematic literature review and meta-analysis of follow-up studies of women with breast cancer.
- Data/sample: English-language articles from OVID MEDLINE and EMBASE through 30 June 2013, plus hand-searching; included studies had to report BMI and total or cause-specific mortality. Final meta-analyses used 79 publications from 82 follow-up studies.
- Main analysis: Random-effects categorical and dose–response meta-analyses, including non-linear dose–response models; heterogeneity assessed with Cochran Q and I², with subgroup/meta-regression, sensitivity analyses, and publication-bias checks using Egger’s test and funnel plots.
## Limitations
- The paper states that most studies did not adjust for co-morbidities and did not assess intentional weight loss; body weight and treatment information were often incomplete or unavailable.
- It notes that reverse causation may have affected studies assessing BMI in women with cancer and other illnesses, and that survival bias in survivor cohorts may underestimate associations.
- The text also says the review could not analyze race/ethnicity or treatment types because too few studies reported them; this is an evident limitation of the evidence base, not just the review.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
0 Valid · 0 Not valid · 9 Not checked · 67 Own results and interpretations
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BMI was significantly associated with breast cancer mortality.”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and breast cancer mortality
states an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The current systematic literature review and meta-analysis extends and confirms the associations of obesity with an unfavourable overall and breast cancer survival in pre and postmenopausal breast cancer, regardless of when BMI is ascertained.”
- Also stated in: § discussion · boosted
“The present systematic literature review and meta-analysis of follow-up studies clearly supports that, in breast cancer survivors, higher BMI is consistently associated with lower overall and breast cancer survival, regardless of when BMI is ascertained.”
- Also stated in: § discussion · plain
“In conclusion, the present systematic literature review and meta-analysis extends and confirms the associations of obesity with an unfavourable overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained.”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > Abstract
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § discussion · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Compared with normal weight women, for BMI before diagnosis, the summary RRs were 1.35 (95% CI 1.24–1.47, 22 studies) for obese women, 1.11 (95% CI 1.06–1.17, 21 studies) for overweight women, and 1.02 (95% CI 0.85–1.21, 8 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and breast cancer mortality
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For BMI ≥12 months after diagnosis, the summary RRs were 1.21 (95% CI 1.06–1.38, 5 studies) for obese women, 0.98 (95% CI 0.86–1.11, 4 studies) for overweight women, and 1.29 (95% CI 1.02–1.63, 3 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and total mortality
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For BMI ≥12 months after diagnosis, the summary RRs were 1.21 (95% CI 1.06–1.38, 5 studies) for obese women, 0.98 (95% CI 0.86–1.11, 4 studies) for overweight women, and 1.29 (95% CI 1.02–1.63, 3 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and total mortality
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
47 more claims
Create a free account to see all 76 claims and to verify the 9 references still open.
- The quote only partly states this claim. 4
- It may state two separate claims as one. 16
- Probably not a substantial claim. 10
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“statistical analysis Categorical and dose-response meta-analyses were conducted using random-effects models to account for between-study heterogeneity[18].”
MethodQuantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · cited 1×
“To assess heterogeneity, we computed the Cochran Q test and I 2 statistic[35].”
MethodFood, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050 · cited 1×
“be obese and 958 million were overweight in 2008[3].”
BackgroundPublication and related bias in meta-analysis
Sterne, J. A. C., Gavaghan, D., & Egger, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00242-0 · Cited by 2,282 · cited 1×
“Small study or publication bias was examined by Egger’s test[36] and visual inspection of the funnel plots.”
MethodNutrition and physical activity guidelines for cancer survivors
Rock, C. L., Doyle, C., Demark‐Wahnefried, W., Meyerhardt, J., Courneya, K. S., Schwartz, A. L., Bandera, E. V., Hamilton, K. K., Grant, B., McCullough, M., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21142 · Cited by 1,995
Self-citationGeneralized Least Squares for Trend Estimation of Summarized Dose–response Data
Orsini, N., Bellocco, R., & Greenland, S. (2006) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0600600103 · Cited by 1,241 · cited 1×
“generalised least-squares for trend estimation[25].”
The use of fractional polynomials to model continuous risk variables in epidemiology
Royston, P., Ambler, G., & Sauerbrei, W. (1999) · International Journal of Epidemiology · doi:10.1093/ije/28.5.964 · Cited by 1,066 · cited 1×
“The non-linear dose-response relationship between BMI and mortality was examined using the best-fitting second order fractional polynomial regression model[23], defined as the one with the lowest deviance.”
MethodFasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 981
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
Protani, M., Coory, M., & Martin, J. H. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0990-0 · Cited by 962 · cited 3×
“A review published in 2010 reported statistically significant increased risks of 33% of both total and breast cancer mortality for obesity versus non-obesity around diagnosis[7].”
Background
Research works printed but not linked: 2
- Tobias A Assessing the influence of a single study in meta-analysis Stata Tech Bull 1999 47 15 17
- Donegan WL Jayich S Koehler MR The prognostic implications of obesity for the surgical cure of breast cancer Breast 1978 4 14 17
Cited by
Items 401–500 of 1,000
Bonet, C., Crous‐Bou, M., Tsilidis, K. K., Gunter, M. J., Kaaks, R., Schulze, M. B., Fortner, R. T., Antoniussen, C. S., Dahm, C. C., Mellemkjær, L., et al. (2023) · European Journal of Epidemiology · doi:10.1007/s10654-023-00979-5 · Cited by 26
“Our estimates were lower than the pooled estimators obtained in a meta-analysis of 82 followup studies [6], where obese patients compared with those with normal weight demonstrated a 41% and 35% increase in the overall and BC-specific mortality, respectively.”
BackgroundResultSelf-citationHarborg, S., Feldt, M., Cronin-Fenton, D. P., Klintman, M., Dalton, S. O., Rosendahl, A. H., & Borgquist, S. (2023) · Cancer & Metabolism · doi:10.1186/s40170-023-00308-0 · Cited by 26
Crispo, A., Augustin, L. S. A., Luongo, A., Calderaio, C., Breda, J., Coluccia, S., Calabrese, A., Marrazzo, V., Giannatiempo, R., Trasacco, P., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-45439-y · Cited by 26
Nimee, F., Gioxari, A., Παπανδρέου, Π., Amerikanou, C., Karageorgopoulou, S., Kaliora, A. C., & Skouroliakou, M. (2024) · Cancers · doi:10.3390/cancers16040802 · Cited by 26
Pelekasis, P., Zisi, G., Koumarianou, A., Marioli, A., Chrousos, G., Syrigos, K., & Darviri, C. (2016) · Integrative Cancer Therapies · doi:10.1177/1534735415598225 · Cited by 23
“Although the beneficial findings in these dimensions are similar to those from previous studies, their importance should not be overlooked, taking into account that there is strong evidence supporting the fact that being overweight and obese after a breast cancer diagnosis predicts cancer and noncancer mortality.(40)…”
ResultLifestyle Interventions to Improve Cardiorespiratory Fitness and Reduce Breast Cancer Recurrence
Haykowsky, M. J., Scott, J. M., Hudson, K. E., & Denduluri, N. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_175349 · Cited by 26
Association between sleep duration and breast cancer incidence: The multiethnic cohort
Shigesato, M., Kawai, Y., Guillermo, C., Youkhana, F., Shvetsov, Y. B., Setiawan, V. W., Haiman, C. A., Marchand, L. L., & Maskarinec, G. (2019) · International Journal of Cancer · doi:10.1002/ijc.32292 · Cited by 26
Wang, K., Wu, Y.-T., Zhang, X., Chen, L., Zhu, W.-M., Zhang, A.-J., Zheng, K., Yin, X.-D., Li, F., Kong, L., et al. (2019) · BioMed Research International · doi:10.1155/2019/3692093 · Cited by 26
“Although a previous meta-analysis [11] identifying 82 follow-up studies suggested that obesity was associated with worse overall and breast cancer specific survival in preand postmenopausal breast cancer, regardless of when BMI was ascertained, our results indicated that OW at diagnosis could be an independent risk fa…”
ResultWellness Coaching: An Intervention to Increase Healthy Behavior in Breast Cancer Survivors
Stan, D. L., Cutshall, S. M., Adams, T. F., Ghosh, K., Clark, M. M., Wieneke, K. C., Kebede, E. B., Donelan-Dunlap, B., Ruddy, K. J., Hazelton, J. K., et al. (2020) · Clinical journal of oncology nursing · doi:10.1188/20.cjon.305-315 · Cited by 26
Body weight and return to work among survivors of early-stage breast cancer
Meglio, A. D., Menvielle, G., Dumas, A., Gbenou, A. S., Pinto, S., Bovagnet, T., Martin, É., Ferreira, A. R., Vanlemmens, L., Arsène, O., et al. (2020) · ESMO Open · doi:10.1136/esmoopen-2020-000908 · Cited by 26
Obesity and Energy Balance Considerations in Triple-Negative Breast Cancer
Berger, E. R., & Iyengar, N. M. (2021) · The Cancer Journal · doi:10.1097/ppo.0000000000000502 · Cited by 26
“There is a substantial body of evidence that links obesity to prognostic outcomes among women with breast cancer.(17,18,106) One of the largest studies that included patients with ER negative and lymph node–negative breast cancer was the NSABP-14 trial, which demonstrated that contralateral breast cancer and overall m…”
BackgroundBuono, G., Crispo, A., Giuliano, M., Angelis, C. D., Schettini, F., Forestieri, V., Lauria, R., Pensabene, M., Laurentiis, M. D., Augustin, L. S. A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22977 · Cited by 26
“[17, 19] Although, neither diabetes nor obesity affected the outcome of our patients, DFS was significantly worse in patients with these two conditions than in patients without them.”
BackgroundCorrelation of BMI with breast cancer subtype and tumour size
Babu, K. G., Anand, A., Lakshmaiah, K. C., Lokanatha, D., Jacob, L. A., Babu, M. S., Lokesh, K. N., Haleshappa, R. A., Rajeev, L. K., Saldanha, S., et al. (2018) · ecancermedicalscience · doi:10.3332/ecancer.2018.845 · Cited by 26
Wang, S., Yang, T., Qiang, W., Zhao, Z., Shen, A., & Zhang, F. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-021-06739-z · Cited by 25
“A retrospective review also confirmed the relationship between weight and BCS [46].”
BackgroundWellberg, E. A., Corleto, K. A., Checkley, L. A., Jindal, S., Johnson, G. C., HIGGINS, J. A., Obeid, S., Anderson, S. M., Thor, A. D., Schedin, P. S., et al. (2022) · Breast Cancer Research · doi:10.1186/s13058-022-01535-x · Cited by 25
“Weight gain in the year prior to, or the year after, diagnosis was associated with up to a 29% increase in breast cancerspecific mortality [5].”
BackgroundAdiponectin: A player in the pathogenesis of hormone-dependent cancers
Tsankof, A., & Τζιόμαλος, Κ. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1018515 · Cited by 25
Na, H., Song, Y., & Lee, H. (2023) · Cancers · doi:10.3390/cancers15020502 · Cited by 25
Yang, H., Liu, L.-Z., & Zhang, X. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02627-2 · Cited by 25
Conte, L., Lupo, R., Lezzi, A., Paolo, V., Rubbi, I., Rizzo, E., Carvello, M., Calabrò, A., Botti, S., Matteis, E. D., et al. (2024) · Clinical Nutrition Open Science · doi:10.1016/j.nutos.2024.02.007 · Cited by 25
Chung, I. Y., Lee, J. W., Lee, J. S., Park, Y. R., Min, Y. H., Lee, Y., Yoon, T. I., Sohn, G., Lee, S. B., Kim, J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170311 · Cited by 25
Ma, Z., Parris, A. B., Howard, E. W., Shi, Y., Yang, S., Jiang, Y., Kong, L., & Yang, X. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy096 · Cited by 25
Lee, S. Y., Kim, C. H., Kim, Y. J., Kwak, H. D., Ju, J. K., & Kim, H. R. (2019) · Annals of Surgical Treatment and Research · doi:10.4174/astr.2019.96.3.116 · Cited by 25
“The association between obesity and cancer recurrence has been widely investigated in breast cancer, and was shown to be associated with local recurrence, distant metastasis, and decreased overall survival [20-22].”
BackgroundKim, J., Kang, D., Nam, S. J., Kim, S. W., Lee, J. E., Yu, J. H., Lee, S. K., Im, Y., Ahn, J. S., Güallar, E., et al. (2019) · Journal of Global Oncology · doi:10.1200/jgo.19.00034 · Cited by 25
Weight loss reduces basal-like breast cancer through kinome reprogramming
Qin, Y., Sundaram, S., Essaid, L., Chen, X., Miller, S. M., Yan, F., Darr, D. B., Galanko, J. A., Montgomery, S. A., Major, M. B., et al. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0300-y · Cited by 25
“Obese women have a higher risk of invasive breast cancer, developing distant metastasis, recurrence, and mortality [9–14].”
BackgroundLifestyle Intervention for Breast Cancer Women
Hwang, E. S., & Nho, J. (2019) · Journal of Lifestyle Medicine · doi:10.15280/jlm.2019.9.1.12 · Cited by 25
“related to breast cancer for overweight or obese patients compared to those with normal weight [25].”
BackgroundEffect of specific educational program on dietary change and weight loss in breast-cancer survivors
Finocchiaro, C., Ossola, M., Monge, T., Fadda, M., Brossa, L., Caudera, V., & Francesco, A. D. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.05.018 · Cited by 25
Local Biomarkers Involved in the Interplay between Obesity and Breast Cancer
Holm, J. B., Rosendahl, A. H., & Borgquist, S. (2021) · Cancers · doi:10.3390/cancers13246286 · Cited by 24
Friedenreich, C. M., Vallance, J. K., McNeely, M. L., Culos-Reed, S. N., Matthews, C. E., Bell, G. J., Mackey, J. R., Kopciuk, K. A., Dickau, L., Wang, Q., et al. (2022) · Cancer Causes & Control · doi:10.1007/s10552-021-01539-6 · Cited by 24
“A systematic review [14] of BMI and mortality in breast cancer included 79 studies that assessed BMI within 12 months of diagnosis.”
BackgroundObesity and breast cancer: Preventive and therapeutic possibilities for bariatric surgery
Crafts, T. D., Tonneson, J. E., Wolfe, B. M., & Stroud, A. (2022) · Obesity · doi:10.1002/oby.23369 · Cited by 24
“They also noted that regardless of when the weight was ascertained, for each 5- kg/m2- increment increase in BMI, the risk of overall and breastcancer- specific mortality increased (28).”
BackgroundBarone, I., Gelsomino, L., Accattatis, F. M., Giordano, F., Győrffy, B., Panza, S., Giuliano, M., Veneziani, B. M., Arpino, G., Angelis, C. D., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04075-w · Cited by 24
Feliciano, E. M. C., Prentice, R. L., Aragaki, A. K., Neuhouser, M. L., Banack, H. R., Kroenke, C. H., Ho, G. Y. F., Zaslavsky, O., Strickler, H. D., Cheng, T. D., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30931 · Cited by 24
Influence of Body Mass Index on Gestation and Delivery in Nulliparous Women: A Cohort Study
Rodríguez-Mesa, N., Robles-Benayas, P., Rodríguez-López, Y., Pérez-Fernández, E. M., & Cobo‐Cuenca, A. I. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16112015 · Cited by 24
“Obesity is considered a risk factor for several diseases and is related to many pathologies, including cardiovascular diseases, type 2 diabetes, hypertension, kidney problems and cancer, such as breast, colon and endometrial cancer [3,4].”
BackgroundLifestyle among long-term survivors of cancers in young adulthood
Bøhn, S., Lie, H. C., Reinertsen, K. V., Fosså, S. D., Haugnes, H. S., Kiserud, C. E., Loge, J. H., Wisløff, T. F., & Thorsen, L. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05445-6 · Cited by 24
Sella, T., Zheng, Y. H., Tan‐Wasielewski, Z., Rosenberg, S. M., Poorvu, P. D., Tayob, N., Ruddy, K. J., Gelber, S. I., Tamimi, R. M., Schapira, L., et al. (2022) · Cancer · doi:10.1002/cncr.34342 · Cited by 24
Laforest, S., Pelletier, M., Denver, N., Poirier, B., Nguyen, S., Walker, B. R., Durocher, F., Homer, N. Z. M., Diorio, C., Andrew, R., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz268 · Cited by 23
“e1514 Laforest et al Steroid Hormones in Breast Adipose Tissue J Clin Endocrinol Metab, April 2020, 105(4):e1504–e1516”
BackgroundInfluentialThe Impact and Safety of GLP‐1 Agents and Breast Cancer
Parsons, K., Montalvo, M., Fischbach, N. A., Taylor, M. A., Alfaro, S., & Lustberg, M. B. (2025) · Cancer Medicine · doi:10.1002/cam4.70932 · Cited by 24
“Both elevated estradiol levels and hyperinsulinemia are correlated with a worse prognosis in breast cancer [15].”
Bankoglu, E. E., & Stopper, H. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.22 · Cited by 23
Acevedo, F., Walbaum, B., Muñiz, S., Militza Petric, G., Martínez, R., Guerra, C., Navarro, M., Córdova‐Delgado, M., Pinto, M. P., & Sanchez, C. G. (2022) · Scientific Reports · doi:10.1038/s41598-022-25043-2 · Cited by 23
Yucel, K. B., Aydos, U., Sütçüoğlu, O., Kılıç, A. C. K., Özdemir, N., Özet, A., & Yazıcı, O. (2024) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-024-04641-z · Cited by 23
Rahman, H. A., Zaim, S. N. N., Suhaimei, U. S., & Jamain, A.-A. (2024) · Diseases · doi:10.3390/diseases12060111 · Cited by 23
“Despite increases in the number of breast cancer survivors due to early diagnosis and advances in treatment [4] breast cancer mortality rate has increased by 21.3% (95% CI: 14.9%, 27.2”
BackgroundInfluentialReichle, K., Peter, R. S., Concin, H., & Nagel, G. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0658-5 · Cited by 23
Ee, C., Cave, A. E., Naidoo, D., Bilinski, K. L., & Boyages, J. (2020) · BMC Women s Health · doi:10.1186/s12905-020-01002-9 · Cited by 23
“A meta-analysis of 82 studies reported a 41% relative increase in all-cause mortality for breast cancer survivors with obesity compared with women of normal weight, with a higher risk in premenopausal women [5].”
BackgroundImpact of obesity, lifestyle factors and health interventions on breast cancer survivors
Campbell, N. J., Barton, C., Cutress, R., & Copson, E. (2022) · Proceedings of The Nutrition Society · doi:10.1017/s0029665122002816 · Cited by 23
Lee, J. M., Abraham, L., Lam, D. L., Buist, D. S. M., Kerlikowske, K. M., Miglioretti, D. L., Houssami, N., Lehman, C. D., Henderson, L. M., & Hubbard, R. A. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.8267 · Cited by 23
Gnagnarella, P., Dragà, D., Baggi, F., Simoncini, M. C., Sabbatini, A., Mazzocco, K., Bassi, F. D., Pravettoni, G., & Maisonneuve, P. (2016) · Trials · doi:10.1186/s13063-016-1487-x · Cited by 22
“[10] demonstrated a 41 % increase in overall mortality in obese and 7 % in overweight women and a 35 % increase in breast cancer-specific mortality in obese women and 11 % in overweight women, as compared with patients who had normal weight at diagnosis.”
ResultWeng, J. K., Lei, X. J., Schlembach, P. J., Bloom, E. S., Shaitelman, S. F., Arzu, I., Chronowski, G. M., Dvořák, T., Grade, E., Hoffman, K. E., et al. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.05.004 · Cited by 22
Terranova, C. O., WINKLER, E. A. H., Healy, G. N., Demark‐Wahnefried, W., Eakin, E., & Reeves, M. M. (2022) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2022.02.009 · Cited by 22
Weight gain in midlife women: Understanding drivers and underlying mechanisms
Grammatikopoulou, M. G., Nigdelis, M. P., & Goulis, D. G. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100406 · Cited by 22
Age, Body Mass Index, Tumor Subtype, and Racial and Ethnic Disparities in Breast Cancer Survival
Lipsyc-Sharf, M. D., Ballman, K. V., Campbell, J. D., Muss, H. B., Perez, E. A., Shulman, L. N., Carey, L., Partridge, A. H., & Warner, E. T. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.39584 · Cited by 22
Tan, L., Mei, J., Tang, R., Huang, D., Qi, K., Ossowski, Z. M., & Wang, X. (2024) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2024.103119 · Cited by 22
Tiainen, S., Oikari, S., Tammi, M., Rilla, K. J., Hämäläinen, K. M., Tammi, R., Kosma, V., & Auvinen, P. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3996-4 · Cited by 22
“More recently, it has been revealed that obesity also impairs the outcome of premenopausal breast cancer patients [32, 33].”
BackgroundPila, E., Sabiston, C. M., Taylor, V. H., & Arbour‐Nicitopoulos, K. P. (2018) · Qualitative Health Research · doi:10.1177/1049732318770403 · Cited by 22
Physical and Mental Health Consequences of Obesity in Women
Weschenfelder, J., Bentley, J., & Himmerich, H. (2018) · InTech eBooks · doi:10.5772/intechopen.73674 · Cited by 22
Trestini, I., Sperduti, I., Caldart, A., Bonaiuto, C., Fiorio, E., Parolin, V., Zambonin, V., Zanelli, S., Tregnago, D., Avancini, A., et al. (2021) · The Breast · doi:10.1016/j.breast.2021.08.008 · Cited by 22
“Particularly, the excess of adiposity may detrimentally affect the quality of life and self-esteem and it may increase the risk of breast cancer recurrence, second primary malignancies [7], glucose and lipid dysregulation and, consequently, comorbidities, such as type 2 diabetes and cardiovascular disease [8] in both…”
BackgroundBurkbauer, L., Goldbach, M. M., Huang, C., Lewandowski, J. T., Krouse, R. S., Allison, K. C., & Tchou, J. C. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06546-y · Cited by 22
“However, obesity is known to increase both disease-specific and all-cause mortality in breast cancer survivors [10], highlighting the need for effective weight loss strategies in this population.”
BackgroundInfluentialAlarfi, H., Salamoon, M., Kadri, M. A. L., Alammar, M., Haykal, M. A., Alseoudi, A., & Youssef, L. A. (2017) · BMC Research Notes · doi:10.1186/s13104-017-2876-2 · Cited by 22
“Adiposity is an established risk factor for recurrence and poor survival in early-stage breast cancer [5, 7], however the link between obesity and treatment outcomes in patients with MBC remains unclear.”
Obesity, Body Composition, and Breast Cancer: An Evolving Science
Bandera, E. V., & John, E. M. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.0125 · Cited by 22
Self-citationZewenghiel, L., Lindman, H., & Valachis, A. (2018) · The Breast · doi:10.1016/j.breast.2018.05.005 · Cited by 22
Kim, J. Y., Lee, D., Lee, K.-H., Min, A., Ryu, H. S., Lee, H., Moon, H., Kim, T., Han, S., Oh, D., et al. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05249-1 · Cited by 21
The effect of modifiable risk factors on breast cancer aggressiveness among black and white women
Killelea, B. K., Gallagher, E. J., Feldman, S. M., Port, E. R., King, T. A., Boolbol, S. K., Franco, R., Fei, K., Roith, D. L., & Bickell, N. A. (2019) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2019.07.012 · Cited by 21
“Obesity at the time of diagnosis, another risk factor for breast cancer,(44) particularly among postmenopausal women, has also been studied extensively, but the findings are mixed.”
BackgroundUrbutė, A., Frederiksen, K., & Kjær, S. K. (2022) · Annals of Epidemiology · doi:10.1016/j.annepidem.2022.03.013 · Cited by 21
Effects of Hyaluronan on Breast Cancer Aggressiveness
Parnigoni, A., Moretto, P., Viola, M., Karousou, E. G., Passi, A. G., & Vigetti, D. (2023) · Cancers · doi:10.3390/cancers15153813 · Cited by 21
Conte, L., Rizzo, E., Civino, E., Tarantino, P., Nunzio, G. D., & Matteis, E. D. (2024) · Applied Sciences · doi:10.3390/app14188474 · Cited by 21
Breast Cancer Research in the Caribbean: Analysis of Reports From 1975 to 2017
Ragin, C. C. R., Banydeen, R., Zhang, C., Ben, A., Calabrese, V., Villa, N., Reville, J., Dasgupta, S., Bandyopadhyay, M., Louden, D. M., et al. (2018) · Journal of Global Oncology · doi:10.1200/jgo.18.00044 · Cited by 21
Body fatness and mTOR pathway activation of breast cancer in the Women’s Circle of Health Study
Cheng, T. D., Omilian, A. R., Yao, S., Sanchez, P. V., Polk, L. Z., Zhang, W., Datta, S., Bshara, W., Ondracek, R. P., Davis, W., et al. (2020) · npj Breast Cancer · doi:10.1038/s41523-020-00187-4 · Cited by 21
Self-citationTaroeno‐Hariadi, K. W., Hardianti, M. S., Sinorita, H., & Aryandono, T. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00621-4 · Cited by 21
“47) compared to normal weight patients [26].”
BackgroundLeVasseur, N., Cheng, W., Mazzarello, S., Clemons, M. J., Vandermeer, L., Jones, L. W., Joy, A. A., Barbeau, P., Wolfe, D. M., Ahmadzai, N., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245794 · Cited by 21
Lorona, N. C., Malone, K. E., & Li, C. I. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06311-7 · Cited by 21
Kohls, M., Freisling, H., Charvat, H., Soerjomataram, I., Viallon, V., Dávila‐Batista, V., Kaaks, R., Fortner, R. T., Aleksandrova, K., Schulze, M. B., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-09589-y · Cited by 21
Wellberg, E. A., Checkley, L. A., Giles, E. D., Johnson, S. J., Oljira, R., Wahdan-Alaswad, R. S., Foright, R. M., Dooley, G. P., Edgerton, S. M., Jindal, S., et al. (2017) · Hormones and Cancer · doi:10.1007/s12672-017-0302-9 · Cited by 21
Qin, B., Llanos, A. A. M., Lin, Y., Szamreta, E. A., Plascak, J. J., Oh, H., Pawlish, K. S., Ambrosone, C. B., Demissie, K., Hong, C., et al. (2018) · Journal of Cancer Survivorship · doi:10.1007/s11764-018-0685-9 · Cited by 21
“They are also risk factors for adverse cancer outcomes, such as a higher risk of all-cause and breast cancerspecific mortality among breast cancer patients [1].”
BackgroundSelf-citationIGF-1 Interacted With Obesity in Prognosis Prediction in HER2-Positive Breast Cancer Patients
Tong, Y., Wu, J., Huang, O., He, J., Zhu, L., Chen, W., Li, Y., Chen, X., & Shen, K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00550 · Cited by 21
“A recent metaanalysis including 213,075 BC patients estimated a 41% and a 7% increased risk of all-cause mortality in obese and overweight patients, respectively, compared to their normal-weight matched controls (35).”
BackgroundWeighing the Risk: effects of Obesity on the Mammary Gland and Breast Cancer Risk
Hillers‐Ziemer, L. E., & Arendt, L. M. (2020) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-020-09452-5 · Cited by 21
Cortesi, L., Sebastiani, F., Iannone, A., Marcheselli, L., Venturelli, M., Piombino, C., Toss, A., & Federico, M. (2020) · Cancers · doi:10.3390/cancers12071709 · Cited by 21
Survival and Recurrence With GLP-1 Receptor Agonists in Breast Cancer
Tatum, K. L., Dahman, B. A., Stevenson, A., Williford, S. E., Cassel, J. B., Zhao, H., Shen, J., McGuire, K. P., Diala, O. R., Oladimeji, R., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.12133 · Cited by 20
Breast cancer outcomes in a population with high prevalence of obesity
Herlevic, V., Mowad, R., Miller, J. K., Darensburg, N. A., Li, B. D. �., & Kim, R. H. (2015) · Journal of Surgical Research · doi:10.1016/j.jss.2015.03.088 · Cited by 20
“[7] Chan DS, Vieira AR, Aune D, et al.”
BackgroundWang, W., Yuan, P., Yu, D., Du, F., Zhu, A., Li, Q., Zhang, P., Lin, D., & Xu, B. (2016) · Oncotarget · doi:10.18632/oncotarget.7920 · Cited by 20
“However, the association between obesity and survival after breast cancer remained controversial for decades until last year; a positive association was demonstrated in meta-analyses of published data [34–35].”
Fassier, P., Zelek, L. H., Bachmann, P., Touillaud, M. S., Druesne‐Pecollo, N., Partula, V., Herçberg, S., Galan, P., Cohen, P., Hoarau, H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17676 · Cited by 20
Schrijnders, D., Hendriks, S. H., Kleefstra, N., Vissers, P. A. J., Johnson, J. A., de Bock, G. H., Bilo, H. J. G., & Landman, G. W. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190870 · Cited by 20
Kwarteng, J. L., Beyer, K. M. M., Banerjee, A., & Stolley, M. R. (2020) · Cancer Causes & Control · doi:10.1007/s10552-020-01315-y · Cited by 20
“Disparities in survival rates are attributed to a myriad of social [2, 3] and individual factors [4], with obesity being one [5].”
BackgroundLigorio, F., Zambelli, L., Fucà, G., Lobefaro, R., Santamaria, M., Zattarin, E., de Braud, F., & Vernieri, C. (2022) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359221079123 · Cited by 20
OuYang, P., Zhang, L.-N., Tang, J., Lan, X., Xiao, Y., Gao, Y., Ma, J., & Xie, F. (2016) · Medicine · doi:10.1097/md.0000000000002380 · Cited by 20
Lohmann, A. E., Ennis, M., Taylor, S. K., & Goodwin, P. J. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4263-z · Cited by 20
Strand, F., Humphreys, K., Holm, J., Eriksson, M., Törnberg, S., Hall, P., Azavedo, E., & Czene, K. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0962-6 · Cited by 20
“, if it was before or after diagnosis, or if it was more or less than 12 months after diagnosis [25].”
BackgroundGong, Y., Ji, P., Sun, W., Jiang, Y.-Z., Hu, X., & Shao, Z. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.08.008 · Cited by 20
Obesity and Oesophageal Cancer
Nimptsch, K., Steffen, A., & Pischon, T. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42542-9_4 · Cited by 20
Uhelski, A.-C. R., Blackford, A. L., Sheng, J. Y.-S., Snyder, C. F., Lehman, J., Visvanathan, K., Lim, D., Stearns, V., & Smith, K. L. (2023) · Journal of Cancer Survivorship · doi:10.1007/s11764-023-01408-y · Cited by 19
Nobrega, G. B., Mota, B. S., de Freitas, G. B., Maesaka, J. Y., Mota, R. M. S., Gonçalves, R., Trinconi, Â. F., Ricci, M. D., Piato, J. R. M., Soares, J. M., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1293288 · Cited by 19
Biskup, M., Macek, P., Terek-Derszniak, M., Žák, M., Król, H., Falana, K., & Góźdź, S. S. (2023) · Diagnostics · doi:10.3390/diagnostics13223447 · Cited by 19
“The relationship between body mass at the time of breast cancer diagnosis and the risk of recurrence or death has been assessed in more than 100 research papers over the last 40 years [56,68–70].”
BackgroundEndocrine health in survivors of adult-onset cancer
Link, C. S., Göbel, A., Jaschke, N., & Rachner, T. D. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00088-3 · Cited by 19
Obesity, overweight and breast cancer: new clinical data and implications for practice
García‐Estévez, L., González-Rodríguez, M., Calvo, I., Orta, A., Gión, M., Moreno‐Bueno, G., Pérez-García, J. M., & Cortés, J. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1579876 · Cited by 19
Fassier, P., Srour, B., Raynard, B., Zelek, L. H., Cohen, P., Bachmann, P., Touillaud, M. S., Druesne‐Pecollo, N., Bellenchombre, L., Cousson‐Gélie, F., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31646 · Cited by 20
Gregori, M. D., Belfer, I., GIORGIO, R. D., Marchesini, M., Muscoli, C., Rondanelli, M., Martini, D., Mena, P. R., Arranz, L. I., Lorente‐Cebrián, S., et al. (2018) · Journal of Pain Research · doi:10.2147/jpr.s160660 · Cited by 19
John, E. M., McGuire, V. M., Kurian, A. W., Koo, J., Shariff‐Marco, S., Gomez, S. L., Cheng, I. C., Keegan, T. H. M., Kwan, M. L., Bernstein, L., et al. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1291 · Cited by 19
Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer Progression
Hinterleitner, C., Zhou, Y., Tandler, C., Heitmann, J. S., Kropp, K. N., Hinterleitner, M., Koch, A., Hartkopf, A. D., Zender, L., Salih, H. R., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.642170 · Cited by 19
“Additionally, the clinical parameter BMI which was found to be negatively associated with overall survival in a meta-analysis of >210,000 breast cancer patients (46) did not correlate with pTACI level or platelet activation in our study.”
BackgroundJeon, Y. W., Park, H. S., Ko, Y., Sung, Y. S., Shim, B. Y., Suh, Y. J., & Kim, H. A. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06322-4 · Cited by 19
Orlandini, L. F., Pimentel, F. F., de Andrade, J. M., dos Reis, F. J. C., Mattos‐Arruda, L. D., & Tiezzi, D. G. (2021) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2021e11409 · Cited by 19
“(6) evaluated four BMI categories among 213,075 patients and concluded that the relative risk in obese versus non-obese patients was 1.”
BackgroundCirculating lipids and breast cancer prognosis in the Malmö diet and cancer study
Harborg, S., Ahern, T. P., Feldt, M., Rosendahl, A. H., Cronin-Fenton, D. P., Melander, O., & Borgquist, S. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06462-7 · Cited by 19
“To improve breast cancer outcomes, there is a need for identifying modifiable causes of breast cancer recurrence (BCR) and breast cancer-related mortality (BCRM) [4].”
BackgroundInfluentialLiving with Advanced Breast Cancer: A Descriptive Analysis of Survivorship Strategies
Grimm, M., Radcliff, L., Giles, M. B., Nash, R. R., Holley, E. E., Panda, S., Brophy, L., Williams, N. O., Cherian, M. A., Stover, D. G., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11143992 · Cited by 19
Chen, D., Wirth, K. M., Kizy, S., Muretta, J. M., Markowski, T. W., Yong, P., Sheka, A. C., Abdelwahab, H., Hertzel, A. V., Ikramuddin, S., et al. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0763 · Cited by 19
Metadata
- Authors
- Chan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T.
- Affiliations
- Imperial College London (GB)
- Norwegian University of Science and Technology (NO)
- Rutgers, The State University of New Jersey (US)
- University of Leeds (GB)
- Fred Hutch Cancer Center (US)
- Oslo University Hospital (NO)
- Newcastle University (GB)
- Corresponding author
- Chan, D.S.M.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 25
- Issue
- 10
- Pages
- 1901-1914
- ISSN
- 0923-7534 (ISSN-L)
- PMC
- PMC4176449
- OpenAlex
- W2149466392
- Cited by
- 1,165
- References
- 123
- Citations by year
- 2026: 57 · 2025: 69 · 2024: 97 · 2023: 117 · 2022: 132 · 2021: 117 · 2020: 121 · 2019: 103 · 2018: 97 · 2017: 98 · 2016: 85 · 2015: 58 · 2014: 12
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 1878 d)
- Locations
- Annals of Oncology (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by-nc-nd)
- HighWire Press Open Archive (submittedVersion)
- Funders
- World Cancer Research Fund International (2007/SP01)
- World Cancer Research Fund International/American Institute for Cancer Research
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- body mass index, breast cancer, obesity, overweight, underweight, survival, mortality, cause-specific mortality, menopausal status, weight loss interventions, cancer survivorship
- MeSH terms
- Breast Neoplasms, Female, Follow-Up Studies, Humans, Obesity, Prognosis, Risk Factors, Body Mass Index, Randomized Controlled Trials as Topic, MEDLINE, Survivors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.